Synthesis and Evaluation of Novel Peroxisome Proliferator Activated Receptor-γ (PPAR-γ) Agonists for the Treatment of Diabetes

Authors

  • Sahil Kumar Department of Pharmaceutical Sciences, Drug Discovery and Research Laboratory, Guru Jambheshwar University of Science and Technology, Hisar, Haryana, India School of Pharmacy and Emerging Sciences, Baddi University of Emerging Sciences & Technology, Baddi, Solan, Himachal Pradesh, India
  • Ashwani Kumar Department of Pharmaceutical Sciences, Drug Discovery and Research Laboratory, Guru Jambheshwar University of Science and Technology, Hisar, Haryana, India

DOI:

https://doi.org/10.37591/rrjot.v6i2.1327

Abstract

A series of novel thiazolidinedione derivatives as peroxisome proliferator activated receptor-gamma (PPAR-gamma) agonists bearing different fatty acid esters and amides as substituents in the positions 3 and 4 of the benzylidene moiety have been designed, synthesized and tested as potential antihyperglycemic agents. The compounds containing stearic acid (A1TU, A2TU, A3TU, A2TS and A3TS) exhibited the maximum activity (64.7-70.3 % BG reduction) among all the synthesized compounds. The capric acid containing compounds (D2TU and D3TU) showed the minimum activity (28.8-36.3 % BG reduction) with exception of D1TU and D1TS which exhibited 57.2 % and 48.7 % of BG reduction respectively. Compounds containing myristic acid (B1TU, B2TU, B3TU, B1TS and B3TS) and palmitic acid (C1TU, C2TU, C3TU, C2TS and C3TS) were found to be less active than stearic acid derivatives but more active than capric acid derivatives.

 

Keywords: PPAR-γ, thiazolidinedione, fatty acids, antihyperglycemic activity

Cite this Article

Ashwani Kumar, Sahil Kumar. Synthesis and Evaluation of Novel Peroxisome Proliferator Activated Receptor-γ (PPAR-γ) Agonists for the Treatment of Diabetes. Research & Reviews: Journal of Toxicology. 2016; 6(2): 1–12p.

Downloads

Published

2019-04-09

Issue

Vol. 6 No. 2 (2016)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.